Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 1829-1833, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Havekes, L.
Right arrow Articles by de Wit, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Havekes, L.
Right arrow Articles by de Wit, E.

Clinical Chemistry, Vol 27, 1829-1833, Copyright © 1981 by American Association for Clinical Chemistry

Low-density-lipoprotein apoprotein B in plasma as measured by radial immunodiffusion and rocket immunoelectrophoresis

L Havekes, J Hemmink and E de Wit

Radial immunodiffusion (RID) and rocket immunoelectrophoresis (RIE) are compared with respect to determination of LDL-bound apo B in plasma. Isolated VLDL could not enter a 15 g/L agarose gel when either technique was used. However, in the presence of plasma proteins, migration of VLDL into agarose was enhanced. Only when plasma samples were kept frozen before the assay was plasma VLDL unable to enter the agarose gel when RID was used. With RIE the contribution of plasma VLDL to the apo B determination under these conditions was not always negligible. Besides enhancing the entry of VLDL into the agarose, the presence of proteins also influences apo B immunoreactivity of LDL and VLDL. For measuring LDL-bound apo B directly in unfractionated plasma we recommend: (a) RID in 15 g/L agarose gel; (b) freezing the plasma samples before assay; (c) diluting the plasma samples in saline supplemented with protein in the same concentration as is present in plasma (70 g/L); and (d) using plasma as the assay standard.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Endocrinol. Metab.Home page
R. G. IJzerman, C. D. A. Stehouwer, M. M. van Weissenbruch, E. J. de Geus, and D. I. Boomsma
Evidence for Genetic Factors Explaining the Association Between Birth Weight and Low-Density Lipoprotein Cholesterol and Possible Intrauterine Factors Influencing the Association Between Birth Weight and High-Density Lipoprotein Cholesterol: Analysis in Twins
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5479 - 5484.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. S. Bachorik, K. L. Lovejoy, M. D. Carroll, and C. L. Johnson
Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III)
Clin. Chem., December 1, 1997; 43(12): 2364 - 2378.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.